Breast Tumor Clinical Trials

5 recruiting

Breast Tumor Trials at a Glance

10 actively recruiting trials for breast tumor are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Pittsburgh, Scottsdale, and Houston. Lead sponsors running breast tumor studies include BriaCell Therapeutics Corporation, Fudan University, and Arbeitsgemeinschaft medikamentoese Tumortherapie.

Browse breast tumor trials by phase

Treatments under study

About Breast Tumor Clinical Trials

Looking for clinical trials for Breast Tumor? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Breast Tumor trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Breast Tumor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Clinical Explorative Optical Breast Investigations

Benign Breast TumorsMalignant Breast TumoursHealthy
Region Skane90 enrolled1 locationNCT06857669
Recruiting
Phase 2

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Breast CancerBreast NeoplasmsHER2-negative Breast Cancer+6 more
QuantumLeap Healthcare Collaborative5,000 enrolled42 locationsNCT01042379
Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Breast CancerLiver CancerEsophageal Cancer+35 more
UMC Utrecht8,000 enrolled18 locationsNCT04075305
Recruiting
Not Applicable

3D Ultrasound Breast Imaging

Breast Tumor
Mayo Clinic125 enrolled1 locationNCT04692818
Recruiting
Not Applicable

HealiAid Collagen Wound Dressing in Patients Undergoing Breast Tumor Surgery

Breast TumorsWound HealingCollagen Wound Dressing
Maxigen Biotech Inc.60 enrolled3 locationsNCT07209020
Recruiting
Phase 2

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Breast CancerBreast NeoplasmCancer of the Breast+1 more
Proton Collaborative Group132 enrolled9 locationsNCT01766297
Recruiting
Phase 2

Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy

Breast CancerBreast NeoplasmBreast Tumors
Fudan University716 enrolled1 locationNCT05582499
Recruiting

Metastatic Breast Cancer in Austria

Breast CancerBreast CarcinomaBreast Tumor
Arbeitsgemeinschaft medikamentoese Tumortherapie5,000 enrolled16 locationsNCT03870620
Recruiting
Phase 1Phase 2

A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer

Breast CancerCancer of the BreastBreast Tumor+3 more
BriaCell Therapeutics Corporation18 enrolled1 locationNCT06471673
Recruiting

AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors

Phyllodes Breast TumorArtificial IntelligenceMultiomics+2 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University4,000 enrolled4 locationsNCT06286267